OCGN Inventory Forecast 2025
The OCGN inventory forecast for 2025 is a subject of great curiosity for buyers and analysts. OCGN, or Ocugen, Inc., is a clinical-stage biopharmaceutical firm centered on growing gene therapies for ocular ailments. The corporate’s lead product candidate, OCU400, is a gene remedy for the therapy of retinitis pigmentosa, a uncommon genetic eye illness that results in imaginative and prescient loss.
